Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
JOHNSON & Johnson's blockbuster psoriasis drug Stelara led to a significant reduction in disease activity in patients with systemic lupus compared with a placebo in a mid-stage clinical trial, according to data released on Saturday.
Stelara, a biotech drug known...